Download PDF
1 / Pages

Other users also viewed these articles

Renal safety outcomes of spironolactone in patients with resistant hypertension Isabel Galceran; Susana Vázquez; Xavier Durán; Sara Outón; Julio Pascual; Anna Oliveras;
Nefrologia (English Version). 2020;40:413-9
Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists U. Verdalles; M. Goicoechea; S. García de Vinuesa; E. Torres; A. Hernández; E. Verde; A. Pérez de José; J. Luño;
Nefrologia (English Version). 2020;40:66-74
Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;
Nefrologia (English Version). 2021;41:258-75